144 related articles for article (PubMed ID: 2562922)
1. Chromosome 7 long arm deletion in myeloid disorders: a narrow breakpoint region in 7q22 defined by molecular mapping.
Kere J; Ruutu T; Davies KA; Roninson IB; Watkins PC; Winqvist R; de la Chapelle A
Blood; 1989 Jan; 73(1):230-4. PubMed ID: 2562922
[TBL] [Abstract][Full Text] [Related]
2. Molecular cytogenetic delineation of deletions and translocations involving chromosome band 7q22 in myeloid leukemias.
Fischer K; Fröhling S; Scherer SW; McAllister Brown J; Scholl C; Stilgenbauer S; Tsui LC; Lichter P; Döhner H
Blood; 1997 Mar; 89(6):2036-41. PubMed ID: 9058725
[TBL] [Abstract][Full Text] [Related]
3. Chromosome 7 long arm deletion breakpoints in preleukemia: mapping by pulsed field gel electrophoresis.
Kere J
Nucleic Acids Res; 1989 Feb; 17(4):1511-20. PubMed ID: 2922284
[TBL] [Abstract][Full Text] [Related]
4. Plasminogen activator inhibitor type 1 gene is located at region q21.3-q22 of chromosome 7 and genetically linked with cystic fibrosis.
Klinger KW; Winqvist R; Riccio A; Andreasen PA; Sartorio R; Nielsen LS; Stuart N; Stanislovitis P; Watkins P; Douglas R
Proc Natl Acad Sci U S A; 1987 Dec; 84(23):8548-52. PubMed ID: 2891140
[TBL] [Abstract][Full Text] [Related]
5. Molecular characterization of chromosome 7 long arm deletions in myeloid disorders.
Kere J; Ruutu T; Lahtinen R; de la Chapelle A
Blood; 1987 Nov; 70(5):1349-53. PubMed ID: 2889483
[TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of the 7q deletion in myeloid disorders.
Lewis S; Abrahamson G; Boultwood J; Fidler C; Potter A; Wainscoat JS
Br J Haematol; 1996 Apr; 93(1):75-80. PubMed ID: 8611479
[TBL] [Abstract][Full Text] [Related]
7. Familial bone marrow monosomy 7. Evidence that the predisposing locus is not on the long arm of chromosome 7.
Shannon KM; Turhan AG; Chang SS; Bowcock AM; Rogers PC; Carroll WL; Cowan MJ; Glader BE; Eaves CJ; Eaves AC
J Clin Invest; 1989 Sep; 84(3):984-9. PubMed ID: 2569483
[TBL] [Abstract][Full Text] [Related]
8. Cytogenetic and molecular delineation of a region of chromosome 7 commonly deleted in malignant myeloid diseases.
Le Beau MM; Espinosa R; Davis EM; Eisenbart JD; Larson RA; Green ED
Blood; 1996 Sep; 88(6):1930-5. PubMed ID: 8822909
[TBL] [Abstract][Full Text] [Related]
9. Delineation of multiple deleted regions in 7q in myeloid disorders.
Tosi S; Scherer SW; Giudici G; Czepulkowski B; Biondi A; Kearney L
Genes Chromosomes Cancer; 1999 Aug; 25(4):384-92. PubMed ID: 10398433
[TBL] [Abstract][Full Text] [Related]
10. c-src is consistently conserved in the chromosomal deletion (20q) observed in myeloid disorders.
Le Beau MM; Westbrook CA; Diaz MO; Rowley JD
Proc Natl Acad Sci U S A; 1985 Oct; 82(19):6692-6. PubMed ID: 2413444
[TBL] [Abstract][Full Text] [Related]
11. Evidence implicating heterozygous deletion of chromosome 7 in the pathogenesis of familial leukemia associated with monosomy 7.
Shannon KM; Turhan AG; Rogers PC; Kan YW
Genomics; 1992 Sep; 14(1):121-5. PubMed ID: 1358790
[TBL] [Abstract][Full Text] [Related]
12. Assignment of CSF-1 to 5q33.1: evidence for clustering of genes regulating hematopoiesis and for their involvement in the deletion of the long arm of chromosome 5 in myeloid disorders.
Pettenati MJ; Le Beau MM; Lemons RS; Shima EA; Kawasaki ES; Larson RA; Sherr CJ; Diaz MO; Rowley JD
Proc Natl Acad Sci U S A; 1987 May; 84(9):2970-4. PubMed ID: 3495006
[TBL] [Abstract][Full Text] [Related]
13. Three new cases of chromosome 3 rearrangement in bands q21 and q26 with abnormal thrombopoiesis bring further evidence to the existence of a 3q21q26 syndrome.
Jotterand Bellomo M; Parlier V; Mühlematter D; Grob JP; Beris P
Cancer Genet Cytogenet; 1992 Apr; 59(2):138-60. PubMed ID: 1581880
[TBL] [Abstract][Full Text] [Related]
14. Deletion mapping of plasminogen activator inhibitor, type I (PLANH1) and beta-glucuronidase (GUSB) in 7q21----q22.
Schwartz CE; Stanislovitis P; Phelan MC; Klinger K; Taylor HA; Stevenson RE
Cytogenet Cell Genet; 1991; 56(3-4):152-3. PubMed ID: 2055109
[TBL] [Abstract][Full Text] [Related]
15. Chromosome 20 deletions in myelodysplastic syndromes and Philadelphia-chromosome-negative myeloproliferative disorders: characterization by molecular cytogenetics of commonly deleted and retained regions.
Douet-Guilbert N; Basinko A; Morel F; Le Bris MJ; Ugo V; Morice P; Berthou C; De Braekeleer M
Ann Hematol; 2008 Jul; 87(7):537-44. PubMed ID: 18350294
[TBL] [Abstract][Full Text] [Related]
16. Chromosome assignment and restriction fragment length polymorphism analysis of the anonymous DNA probe B79a at 7q22 (HMG8 assignment D7S13).
Estivill X; Schmidtke J; Williamson R; Wainwright B
Hum Genet; 1986 Nov; 74(3):320-2. PubMed ID: 2877942
[TBL] [Abstract][Full Text] [Related]
17. A summary of 7q interstitial deletions and exclusion mapping of the gene for beta-glucuronidase.
Fagan K; Gill A; Henry R; Wilkinson I; Carey B
J Med Genet; 1989 Oct; 26(10):619-25. PubMed ID: 2486209
[TBL] [Abstract][Full Text] [Related]
18. Detection of chromosome 20q deletions in bone marrow metaphases but not peripheral blood granulocytes in patients with myeloproliferative disorders or myelodysplastic syndromes.
Asimakopoulos FA; Holloway TL; Nacheva EP; Scott MA; Fenaux P; Green AR
Blood; 1996 Feb; 87(4):1561-70. PubMed ID: 8608248
[TBL] [Abstract][Full Text] [Related]
19. High-resolution deletion mapping of chromosome arm 17p in childhood primitive neuroectodermal tumors reveals a common chromosomal disruption within the Smith-Magenis region, an unstable region in chromosome band 17p11.2.
Scheurlen WG; Seranski P; Mincheva A; Kühl J; Sörensen N; Krauss J; Lichter P; Poustka A; Wilgenbus KK
Genes Chromosomes Cancer; 1997 Jan; 18(1):50-8. PubMed ID: 8993980
[TBL] [Abstract][Full Text] [Related]
20. Chromosome 7 monosomy and deletions in myeloproliferative diseases.
Tripputi P; Cassani B; Alfano R; Graziani D; Cigognini D; Doi P; Bignotto M; Corneo G; Coggi G
Leuk Res; 2001 Sep; 25(9):735-9. PubMed ID: 11489466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
